Blood test may spot hidden infections in lung cancer patients
NCT ID NCT02821949
First seen Jun 23, 2026 · Last updated Jun 23, 2026
Summary
This study looked at whether measuring procalcitonin (PCT) levels in the blood could help detect infections earlier in people with stage IV non-small cell lung cancer starting chemotherapy. Researchers enrolled 45 patients and took a PCT blood sample before their first chemo session, without telling their doctors the results. They then followed patients for 30 days to see if any developed infections. The goal was to see if PCT could be a more reliable infection marker than the standard CRP test in these patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELLS LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU Amiens
Amiens, 80054, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
procalcitonin (PCT) blood test
What this could lead to
If successful, this could provide a simple blood test to help doctors spot infections earlier in advanced lung cancer patients on chemotherapy.
What could go wrong
This is a small, early observational study with only 45 participants. It does not test any treatment, so it cannot directly improve patient outcomes.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.